Date	Application Number	Sponsor	Product Name	Species	Indications for Use/Effect of the Supplement	Public Documents
October 20, 2023	NADA 141-564	Pharmgate Inc.	Pennchlor and Rumensin (chlortetracyclinel and monensin)	Replacement beef and dairy heifers	This supplement provides for the addition of replacement beef and dairy heifers with the following indications: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in replacement beef and dairy heifers; and For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline and for increased rate of weight gain in replacement beef and dairy heifers.	FOI Summary
October 13, 2023	NADA 141-336	ECO LLC	AIVLOSIN (62.5% w/w tylvalosin as tylvalosin tartrate)	Female swine intended for breeding (replacement gilts, gestating replacement gilts, gestating sows, lactating sows, and weaned sows)	This supplement provides for the addition of female swine intended for breeding (replacement gilts, gestating replacement gilts, gestating sows, lactating sows, and weaned sows) to the classes approved for the control of porcine proliferative enteropathy and control of swine respiratory disease indications, and provides for removal of the precaution “Not for use in lactating or pregnant females or females intended for breeding” from the labeling.	FOI Summary
October 11, 2023	NADA 141-572	Virbac AH, Inc.	AYRADIA (metronidazole)	Dogs	For the treatment of Giardia duodenalis infection in dogs.	FOI Summary